Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women

ClinicalTrials.gov ID: NCT00683800

Public ClinicalTrials.gov record NCT00683800. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 12:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Study Assessing The Safety And Efficacy Of DVS SR For The Treatment Of Vasomotor Symptoms Associated With Menopause

Study identification

NCT ID
NCT00683800
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
2,186 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • desvenlafaxine succinate (DVS) SR Drug

Drug

Eligibility (public fields only)

Age range
45 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2008
Primary completion
Apr 30, 2010
Completion
Apr 30, 2010
Last update posted
Aug 16, 2011

2008 – 2010

United States locations

U.S. sites
102
U.S. states
41
U.S. cities
89
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35235
Pfizer Investigational Site Mobile Alabama 36608
Pfizer Investigational Site Montgomery Alabama 36106
Pfizer Investigational Site Glendale Arizona 85308
Pfizer Investigational Site Peoria Arizona 85381
Pfizer Investigational Site Tucson Arizona 85710
Pfizer Investigational Site Tucson Arizona 85712
Pfizer Investigational Site Tucson Arizona 85715
Pfizer Investigational Site Jonesboro Arkansas 72401
Pfizer Investigational Site Little Rock Arkansas 72205
Pfizer Investigational Site Little Rock Arkansas 72223
Pfizer Investigational Site San Diego California 92103
Pfizer Investigational Site San Diego California 92108
Pfizer Investigational Site San Diego California 92123
Pfizer Investigational Site Vista California 92083
Pfizer Investigational Site Walnut Creek California 94598
Pfizer Investigational Site Colorado Springs Colorado 80910
Pfizer Investigational Site Denver Colorado 80218
Pfizer Investigational Site Englewood Colorado 80112
Pfizer Investigational Site Longmont Colorado 80501
Pfizer Investigational Site New London Connecticut 06320
Pfizer Investigational Site Newark Delaware 19713
Pfizer Investigational Site Brooksville Florida 34601
Pfizer Investigational Site Clearwater Florida 33759
Pfizer Investigational Site Clearwater Florida 33761
Pfizer Investigational Site Daytona Beach Florida 32114
Pfizer Investigational Site Fort Myers Florida 33916
Pfizer Investigational Site Gainesville Florida 32610
Pfizer Investigational Site Lake Worth Florida 33461
Pfizer Investigational Site New Port Richey Florida 34652
Pfizer Investigational Site Palm Harbor Florida 34684
Pfizer Investigational Site Pembroke Pines Florida 33024
Pfizer Investigational Site South Miami Florida 33143
Pfizer Investigational Site Tampa Florida 33606
Pfizer Investigational Site West Palm Beach Florida 33409
Pfizer Investigational Site Atlanta Georgia 30342
Pfizer Investigational Site Decatur Georgia 30033
Pfizer Investigational Site Decatur Georgia 30319
Pfizer Investigational Site Savannah Georgia 31406
Pfizer Investigational Site Boise Idaho 83702
Pfizer Investigational Site Idaho Falls Idaho 83404
Pfizer Investigational Site Indianapolis Indiana 46202
Pfizer Investigational Site Indianapolis Indiana 46260
Pfizer Investigational Site South Bend Indiana 46601
Pfizer Investigational Site Overland Park Kansas 66210
Pfizer Investigational Site Lexington Kentucky 40509
Pfizer Investigational Site Louisville Kentucky 40291
Pfizer Investigational Site New Orleans Louisiana 70114
Pfizer Investigational Site Scarborough Maine 04074
Pfizer Investigational Site Ann Arbor Michigan 48106
Pfizer Investigational Site Brooklyn Center Minnesota 55430
Pfizer Investigational Site Creve Coeur Missouri 63141
Pfizer Investigational Site Billings Montana 59101
Pfizer Investigational Site Billings Montana 59102
Pfizer Investigational Site Lincoln Nebraska 68510
Pfizer Investigational Site Las Vegas Nevada 89109
Pfizer Investigational Site Las Vegas Nevada 89146
Pfizer Investigational Site Reno Nevada 89502
Pfizer Investigational Site Lebanon New Hampshire 03756
Pfizer Investigational Site New Brunswick New Jersey 08901
Pfizer Investigational Site Albuquerque New Mexico 87102
Pfizer Investigational Site New York New York 10032
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Bismarck North Dakota 58501
Pfizer Investigational Site Fargo North Dakota 58104
Pfizer Investigational Site Jamestown North Dakota 58401
Pfizer Investigational Site Akron Ohio 44311
Pfizer Investigational Site Cincinnati Ohio 45267-0457
Pfizer Investigational Site Cleveland Ohio 44122
Pfizer Investigational Site Englewood Ohio 45322
Pfizer Investigational Site Oklahoma City Oklahoma 73112-4481
Pfizer Investigational Site Eugene Oregon 97401
Pfizer Investigational Site Medford Oregon 97504
Pfizer Investigational Site Erie Pennsylvania 16502
Pfizer Investigational Site Erie Pennsylvania 16507-1411
Pfizer Investigational Site Jenkintown Pennsylvania 19046
Pfizer Investigational Site Philadelphia Pennsylvania 19114
Pfizer Investigational Site Pittsburgh Pennsylvania 15206
Pfizer Investigational Site Wexford Pennsylvania 15090
Pfizer Investigational Site Warwick Rhode Island 02886
Pfizer Investigational Site Greer South Carolina 29651
Pfizer Investigational Site Hilton Head Island South Carolina 29926
Pfizer Investigational Site Sioux Falls South Dakota 57104
Pfizer Investigational Site Sioux Falls South Dakota 57105
Pfizer Investigational Site Watertown South Dakota 57201
Pfizer Investigational Site Chattanooga Tennessee 37404
Pfizer Investigational Site Knoxville Tennessee 37920
Pfizer Investigational Site Nashville Tennessee 37203
Pfizer Investigational Site Dallas Texas 75234
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Midland Texas 79705
Pfizer Investigational Site Plano Texas 75093
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Waco Texas 76712
Pfizer Investigational Site Salt Lake City Utah 84117
Pfizer Investigational Site Sandy City Utah 84070
Pfizer Investigational Site Burlington Vermont 05401
Pfizer Investigational Site Norfolk Virginia 23502
Pfizer Investigational Site Norfolk Virginia 23507
Pfizer Investigational Site Richmond Virginia 23294
Pfizer Investigational Site Seattle Washington 98105
Pfizer Investigational Site Menomonee Falls Wisconsin 53051

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00683800, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 16, 2011 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00683800 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →